Skip to main content

Table 3 Multivariate analysis of platelet reactivity in patients under prasugrel

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

 

Coefficient (SE)

t

95 % CI

Exponentiated coefficient*

p-value

Male gender

0.07 (0.14)

0.25

−0.21 to 0.35

1.07

0.6

Current smoking

0.01 (0.16)

0.003

−0.31 to 0.33

1.01

0.9

-Insulin-treated diabetes mellitus (vs non-diabetic status)

0.42 (0.12)

12.0

0.18 to 0.65

1.52

0.001

-Non insulin-treated diabetes mellitus (vs non-diabetic status)

0.03 (0.11)

0.09

−0.19 to 0.25

1.03

0.8

Age

0.001 (0.004)

0.02

−0.007 to 0.008

1.001

0.9

Body mass index

0.02 (0.009)

3.35

−0.001 to 0.033

1.02

0.07

Creatinine clearance < 60 ml/min

−0.07 (0.18)

0.15

−0.42 to 0.28

0.93

0.7

Statin

−0.03 (0.38)

0.006

−0.77 to 0.71

0.97

0.9

Proton pump inhibitor

0.14 (0.19)

0.58

−0.22 to 0.50

1.15

0.4

Hypertension

0.07 (0.08)

0.88

−0.08 to 0.22

1.07

0.4

STEMI at admission

−0.12 (0.08)

2.0

−0.27 to 0.04

0.89

0.2

  1. Abbreviations as in Table 2